DK0489032T3 - Hydroxaminsyre-baserede kollagenaseinhibitorer - Google Patents
Hydroxaminsyre-baserede kollagenaseinhibitorerInfo
- Publication number
- DK0489032T3 DK0489032T3 DK90911398.7T DK90911398T DK0489032T3 DK 0489032 T3 DK0489032 T3 DK 0489032T3 DK 90911398 T DK90911398 T DK 90911398T DK 0489032 T3 DK0489032 T3 DK 0489032T3
- Authority
- DK
- Denmark
- Prior art keywords
- hydroxamic acid
- collagenase inhibitors
- based collagenase
- disease
- involving
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/36—Oxygen or sulfur atoms
- C07D207/38—2-Pyrrolones
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB898919251A GB8919251D0 (en) | 1989-08-24 | 1989-08-24 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0489032T3 true DK0489032T3 (da) | 1995-01-30 |
Family
ID=10662057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK90911398.7T DK0489032T3 (da) | 1989-08-24 | 1990-07-20 | Hydroxaminsyre-baserede kollagenaseinhibitorer |
Country Status (16)
Country | Link |
---|---|
US (2) | US5453438A (ko) |
EP (1) | EP0489032B1 (ko) |
JP (1) | JP2871849B2 (ko) |
KR (1) | KR927003624A (ko) |
AT (1) | ATE111443T1 (ko) |
AU (1) | AU639706B2 (ko) |
CA (1) | CA2064786A1 (ko) |
DE (1) | DE69012575T2 (ko) |
DK (1) | DK0489032T3 (ko) |
ES (1) | ES2063975T3 (ko) |
FI (1) | FI920771A0 (ko) |
GB (1) | GB8919251D0 (ko) |
NO (1) | NO920702L (ko) |
NZ (1) | NZ235050A (ko) |
TW (1) | TW202456B (ko) |
WO (1) | WO1991002716A2 (ko) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8827308D0 (en) * | 1988-11-23 | 1988-12-29 | British Bio Technology | Compounds |
US5892112A (en) * | 1990-11-21 | 1999-04-06 | Glycomed Incorporated | Process for preparing synthetic matrix metalloprotease inhibitors |
US5268384A (en) * | 1990-11-21 | 1993-12-07 | Galardy Richard E | Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors |
EP0520573A1 (en) * | 1991-06-27 | 1992-12-30 | Glaxo Inc. | Cyclic imide derivatives |
DE69309047T2 (de) * | 1992-04-07 | 1997-09-11 | British Biotech Pharm | Hydroxamsäure enthaltende collagenase-inhibitoren und cytokinaktivitätsinhibitoren |
GB9211706D0 (en) * | 1992-06-03 | 1992-07-15 | Celltech Ltd | Peptidyl derivatives |
GB9211707D0 (en) * | 1992-06-03 | 1992-07-15 | Celltech Ltd | Peptidyl derivatives |
US5326760A (en) * | 1992-06-29 | 1994-07-05 | Glaxo, Inc. | Aminobutanoic acid compounds having metalloprotease inhibiting properties |
GB9215665D0 (en) * | 1992-07-23 | 1992-09-09 | British Bio Technology | Compounds |
GB9223904D0 (en) * | 1992-11-13 | 1993-01-06 | British Bio Technology | Inhibition of cytokine production |
US5646167A (en) * | 1993-01-06 | 1997-07-08 | Ciba-Geigy Corporation | Arylsulfonamido-substituted hydroxamix acids |
CA2158352A1 (en) * | 1993-03-16 | 1994-09-29 | Michael John Crimmin | Hydroxamic acid derivatives as metalloproteinase inhibitors |
GB9308695D0 (en) * | 1993-04-27 | 1993-06-09 | Celltech Ltd | Peptidyl derivatives |
ES2134939T3 (es) * | 1993-04-27 | 1999-10-16 | Celltech Therapeutics Ltd | Derivados de peptidilo como inhibidores de metaloproteinas. |
ES2075797B1 (es) * | 1993-08-18 | 1996-05-16 | British Bio Technology | Derivados de acidos hidroxamicos terapeuticamente activos, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y el uso de dichos compuestos en medicina. |
ES2075798B1 (es) * | 1993-08-18 | 1996-03-01 | British Bio Technology | Derivados de aminoacidos naturales como inhibidores de metaloproteinasas, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y el uso de dichos compuestos en medicina. |
US6037472A (en) * | 1993-11-04 | 2000-03-14 | Syntex (U.S.A.) Inc. | Matrix metalloprotease inhibitors |
BR9506535A (pt) * | 1994-01-20 | 1997-09-16 | British Biotech Pharm | Inibidores de metaloproteinases |
GB9501737D0 (en) * | 1994-04-25 | 1995-03-22 | Hoffmann La Roche | Hydroxamic acid derivatives |
US5831004A (en) * | 1994-10-27 | 1998-11-03 | Affymax Technologies N.V. | Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use |
US5840698A (en) * | 1994-10-27 | 1998-11-24 | Affymax Technologies N.V. | Inhibitors of collagenase-1 and stormelysin-I metalloproteases, pharmaceutical compositions comprising same and methods of their use |
GB9423914D0 (en) * | 1994-11-26 | 1995-01-11 | British Biotech Pharm | Polyether derivatives as metalloproteinase inhibitors |
US5639746A (en) * | 1994-12-29 | 1997-06-17 | The Procter & Gamble Company | Hydroxamic acid-containing inhibitors of matrix metalloproteases |
US5919940A (en) * | 1995-01-20 | 1999-07-06 | British Biotech Pharmaceuticals Limited | Metalloproteinase inhibitors |
US5672598A (en) * | 1995-03-21 | 1997-09-30 | The Procter & Gamble Company | Lactam-containing hydroxamic acids |
US5917090A (en) * | 1995-06-30 | 1999-06-29 | British Biotech Pharmaceuticals Ltd. | Matrix metalloproteinase inhibitors |
NZ322553A (en) | 1995-11-23 | 1998-12-23 | British Biotech Pharm | Metalloproteinase inhibitors |
CA2264045A1 (en) * | 1996-08-28 | 1998-03-05 | Randall Stryker Matthews | Heterocyclic metalloprotease inhibitors |
CN1228772A (zh) | 1996-08-28 | 1999-09-15 | 普罗克特和甘保尔公司 | 杂环金属蛋白酶抑制剂 |
KR20000035918A (ko) * | 1996-08-28 | 2000-06-26 | 데이비드 엠 모이어 | 1,3-디헤테로시클릭 메탈로프로테아제 저해제 |
KR20000035925A (ko) * | 1996-08-28 | 2000-06-26 | 데이비드 엠 모이어 | 매트릭스 메탈로프로테아제 저해제인 포스핀산 아미드 |
ATE272062T1 (de) * | 1996-08-28 | 2004-08-15 | Procter & Gamble | Spirocyclisch metalloprotease inhibitoren |
PL191366B1 (pl) | 1996-09-10 | 2006-05-31 | Vernalis Oxford Ltd | Zastosowanie pochodnych kwasu hydroksamowego, pochodne kwasu hydroksamowego oraz kompozycje farmaceutyczne je zawierające |
US6462023B1 (en) | 1996-09-10 | 2002-10-08 | British Biotech Pharmaceuticals, Ltd. | Cytostatic agents |
US5840974A (en) * | 1996-12-04 | 1998-11-24 | Britisch Biotech Pharmaceuticals, Ltd. | Metalloproteinase inhibitors |
US5952320A (en) * | 1997-01-07 | 1999-09-14 | Abbott Laboratories | Macrocyclic inhibitors of matrix metalloproteinases and TNFα secretion |
US5985911A (en) * | 1997-01-07 | 1999-11-16 | Abbott Laboratories | C-terminal ketone inhibitors of matrix metalloproteinases and TNFα secretion |
JP2001513484A (ja) | 1997-07-31 | 2001-09-04 | ザ プロクター アンド ギャンブル カンパニー | 非環式メタロプロテアーゼ阻害剤 |
GB9810464D0 (en) * | 1998-05-16 | 1998-07-15 | British Biotech Pharm | Hydroxamic acid derivatives |
US6288261B1 (en) | 1998-12-18 | 2001-09-11 | Abbott Laboratories | Inhibitors of matrix metalloproteinases |
HUP0202199A2 (en) | 1999-03-03 | 2002-10-28 | Procter & Gamble | Alkenyl- and alkynyl-containing metalloprotease inhibitors |
JP2003506438A (ja) | 1999-08-10 | 2003-02-18 | ブリティッシュ バイオテック ファーマシューティカルズ リミテッド | 抗菌剤 |
GB9929527D0 (en) * | 1999-12-14 | 2000-02-09 | Smithkline Beecham Plc | Novel compounds |
US6797820B2 (en) * | 1999-12-17 | 2004-09-28 | Vicuron Pharmaceuticals Inc. | Succinate compounds, compositions and methods of use and preparation |
AR036053A1 (es) | 2001-06-15 | 2004-08-04 | Versicor Inc | Compuestos de n-formil-hidroxilamina, un proceso para su preparacion y composiciones farmaceuticas |
ATE360014T1 (de) | 2001-06-15 | 2007-05-15 | Vicuron Pharm Inc | Bicyclische pyrrolidinverbindungen |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4105789A (en) * | 1976-05-10 | 1978-08-08 | E. R. Squibb & Sons, Inc. | Carboxyalkylacylamino acids |
IL58849A (en) * | 1978-12-11 | 1983-03-31 | Merck & Co Inc | Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them |
US4499079A (en) * | 1982-11-18 | 1985-02-12 | E. R. Squibb & Sons, Inc. | Carboxy and substituted carboxy alkanoyl and cycloalkanoyl peptides |
US4496540A (en) * | 1982-12-30 | 1985-01-29 | Biomeasure, Inc. | Therapeutic compounds |
JPS6115840A (ja) * | 1984-07-03 | 1986-01-23 | Microbial Chem Res Found | 免疫賦活剤 |
US4599361A (en) * | 1985-09-10 | 1986-07-08 | G. D. Searle & Co. | Hydroxamic acid based collagenase inhibitors |
US4743587A (en) * | 1985-09-10 | 1988-05-10 | G. D. Searle & Co. | Hydroxamic acid based collagenase inhibitors |
DK77487A (da) * | 1986-03-11 | 1987-09-12 | Hoffmann La Roche | Hydroxylaminderivater |
FR2609289B1 (fr) * | 1987-01-06 | 1991-03-29 | Bellon Labor Sa Roger | Nouveaux composes a activite d'inhibiteurs de collagenase, procede pour les preparer et compositions pharmaceutiques contenant ces composes |
-
1989
- 1989-08-24 GB GB898919251A patent/GB8919251D0/en active Pending
-
1990
- 1990-07-20 ES ES90911398T patent/ES2063975T3/es not_active Expired - Lifetime
- 1990-07-20 EP EP90911398A patent/EP0489032B1/en not_active Expired - Lifetime
- 1990-07-20 US US07/820,664 patent/US5453438A/en not_active Expired - Fee Related
- 1990-07-20 WO PCT/GB1990/001117 patent/WO1991002716A2/en active IP Right Grant
- 1990-07-20 JP JP2510523A patent/JP2871849B2/ja not_active Expired - Fee Related
- 1990-07-20 DE DE69012575T patent/DE69012575T2/de not_active Expired - Fee Related
- 1990-07-20 CA CA002064786A patent/CA2064786A1/en not_active Abandoned
- 1990-07-20 DK DK90911398.7T patent/DK0489032T3/da active
- 1990-07-20 AT AT90911398T patent/ATE111443T1/de not_active IP Right Cessation
- 1990-07-20 KR KR1019920700412A patent/KR927003624A/ko not_active Application Discontinuation
- 1990-07-20 AU AU60454/90A patent/AU639706B2/en not_active Ceased
- 1990-08-01 TW TW079106338A patent/TW202456B/zh active
- 1990-08-24 NZ NZ235050A patent/NZ235050A/en unknown
-
1992
- 1992-02-21 NO NO92920702A patent/NO920702L/no unknown
- 1992-02-21 FI FI920771A patent/FI920771A0/fi not_active Application Discontinuation
-
1995
- 1995-04-05 US US08/417,095 patent/US5910609A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
DE69012575T2 (de) | 1995-03-30 |
ES2063975T3 (es) | 1995-01-16 |
WO1991002716A3 (en) | 1991-06-27 |
EP0489032B1 (en) | 1994-09-14 |
JPH05501864A (ja) | 1993-04-08 |
FI920771A0 (fi) | 1992-02-21 |
AU639706B2 (en) | 1993-08-05 |
KR927003624A (ko) | 1992-12-18 |
EP0489032A1 (en) | 1992-06-10 |
US5910609A (en) | 1999-06-08 |
CA2064786A1 (en) | 1991-02-25 |
NZ235050A (en) | 1991-12-23 |
NO920702L (no) | 1992-04-23 |
GB8919251D0 (en) | 1989-10-04 |
WO1991002716A2 (en) | 1991-03-07 |
NO920702D0 (no) | 1992-02-21 |
AU6045490A (en) | 1991-04-03 |
TW202456B (ko) | 1993-03-21 |
ATE111443T1 (de) | 1994-09-15 |
DE69012575D1 (de) | 1994-10-20 |
US5453438A (en) | 1995-09-26 |
JP2871849B2 (ja) | 1999-03-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK0489032T3 (da) | Hydroxaminsyre-baserede kollagenaseinhibitorer | |
DE69734661D1 (de) | Foerderung der wundheilung durch chemisch modifizierte tetracycline | |
ES2063334T3 (es) | Inhibidores de la colagenasa basados en el acido hidroxamico. | |
DK0766664T3 (da) | Metalloproteinaseinhibitorer | |
ATE240744T1 (de) | Verwendung von csf-1-inhibitoren | |
ATE319447T1 (de) | Pharmazeutische zubereitungen die clavulansäure oder derivate enthalten zur behandlund von neurologischen störungen | |
ES2148229T3 (es) | Eteres y tioeteres en la posicion 17 de 4-aza-esteroides. | |
DK1030836T3 (da) | Hydroxam- og carboxylsyrederivater der har MMP- og TNF-inhiberende aktivitet | |
CY1105501T1 (el) | Συνδυασμοι φαρμακων (π.χ. chlorpromazine και pentamidine) για την αντιμετωπιση νεοπλαστικων διαταραχων | |
CY1110521T1 (el) | Υποκατεστημενα ινδολια για τη διαμορφωση της nfkb-ενεργοτητας | |
IT8268130A0 (it) | Dispositivo per l applicazione di un campo elettromagnetico ad alta frequenza ad un tessuto vivente per favorirne la cicatrizzazione | |
DK96691A (da) | Hydroxamsyrebaserede collagenaseinhibitorer | |
DE60138549D1 (de) | Topische gel-abgabesysteme zur behandlung von hauterkrankungen | |
ATE191472T1 (de) | Neuartige metalloprotease-inhibitoren und diese enthaltende pharmazeutische zusammensetzungen | |
TR200101905T2 (tr) | Endotelin ile ilgili hastalıkların tedavisinde kullanılan sülfanoamidler. | |
EA199900542A1 (ru) | Соединения сульфоновой кислоты или сульфониламино-n-(гетероаралкил)-азагетероциклиламида | |
ATE271861T1 (de) | Verwendung von nmda-antagonisten und/oder natriumkanalantagonisten zur behandlung von entzündlichen erkrankungen | |
DE69419954T2 (de) | Arzneimittel zur Behandlung von Hauterkrankungen | |
DK0588477T3 (da) | Medicinsk præparat omfatende TCF-11 | |
DE69828638D1 (de) | Hydroxam- und carbonsäurederivate mit mmp- und tnf-hemmender aktivität | |
RU94014833A (ru) | Средство для лечения дегенеративных заболеваний суставов и околосуставных тканей | |
ATE329613T1 (de) | Wachstumhormone inhibitoren enthaltende pharmazeutische zubereitungen oder ihre biologisch aktive fragmente zur behandlung von uterinen myomas | |
NO20082302L (no) | Anvendelse av et pleuromutilinderivat innen vetrinaermedisin samt fremgangsmate for fremstilling av et medikament omfattende forbindelsen | |
IT8919802A0 (it) | Composto utile per il trattamento terapeutico e la profilassi nella patologia cutanea fotocondizionata. |